Clinical & Diagnostic
Cellenkos Doses First Patient with CK0803 Cell Therapy for ALS Treatment
Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for treatment...
May 03, 2023 | News
Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment
MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...
May 02, 2023 | News
FDA Approves Teva and MedinCell's UZEDY™ for Adult Schizophrenia Treatment
This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...
May 01, 2023 | Regulatory
Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023
–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...
May 01, 2023 | News
Toshiba's Heavy Ion Therapy System treats patients at Yonsei University Health System.
Toshiba Energy Systems & Solutions Corporation (hereinafter "Toshiba ESS") is pleased to announce today the commencement of treatment using a heavy ion...
April 30, 2023 | News
Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
April 26, 2023 | News
SCG Cell Therapy to Highlight Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma at ISCT
"These exciting new data being presented at ISCT continue to reinforce the potential for viral antigen specific TCR-T product to effectively treat infectio...
April 24, 2023 | News
Roche's Tecentriq plus Avastin Reduces Cancer Return Risk in Phase III Liver Cancer Study
In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq plus Avastin reduced the...
April 17, 2023 | News
Zenshine's ZX-7101A Meets Primary Endpoint in Phase 2 Study for Adult Flu Treatment
Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...
April 17, 2023 | News
Zenshine's ZX-7101A meets primary endpoint in Phase 2 flu treatment study
Interim analysis of the phase 2 cohort of ZX-7101A phase 2/3 adaptive design pivotal study (registration number: CTR20221729), a multicenter, randomized, d...
April 14, 2023 | News
JW Therapeutics' Relma-cel approved for systemic lupus erythematosus trial.
SLE is a complex autoimmune disease with diverse clinical manifestations involving many organs and systems. It is estimated that China has 1 mill...
April 11, 2023 | News
Airlangga University Hospital signs MOU with Singapore's Icon Cancer Center
As the first hospital in Indonesia to cooperate with Icon Cancer Center, Airlangga University Hospital is supporting the government's efforts to promote he...
April 10, 2023 | News
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio
Jingsong Wang, MD, PhD, Chairman of Nona Biosciences, said, " By combining our respective expertise in antibody engineering and the disease area, we a...
April 06, 2023 | News
Metabolon Launches Targeted Panels to Study Microbiome and Gut Metabolome in Health and Disease
Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and pr...
April 05, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
